Levetiracetam is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed epilepsy.
Levetiracetam is indicated as adjunctive therapy
In the treatment of partial onset seizures with or without secondary generalisation in adults, adolescents, children and infants from 1 month of age with epilepsy.
In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.
In the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.
Additional Information
Delivery Time10 Days
Interested in this product? Ask for more details & Latest Price from seller
Enzymes Pharmaceuticals was established with the aim of building bridge beyond the border to provide best services for human being by manufacturing, marketing and supplying Human medicines with best quality. With the help of qualified and experienced staff, Enzymes Pharmaceuticals is growing with a growth rate of 50% every Year.
Nature of Business Manufacturer / Exporter / Service Provider / Supplier
Year of Establishment2016
Tell us your Buy Requirement to Get Instant Response